Clinical Trials Browser

Neoplasms × CP protocol × 1 year × Clear all

NCT07102940 2026-02-20

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasms

NCT03307785 2025-11-25

Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

Phase 1 Completed

60 enrolled 91 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms